Establishment of a Tumor Bank for Tissue Samples
Establishment of a Tissue Sample Bank in the Field of Gynaecological Oncology
Medical University of Vienna
10,000 participants
Sep 1, 2003
OBSERVATIONAL
Conditions
Summary
Establishment of a tumor bank, consisting of tissue samples of tumor patients (benign and malign tumors) and healthy people as controls. The tissue samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tissue tumor bank. This tumor bank for tissue samples, together with our tumorbank for blood samples (NCT01763125) combined constitute the entity "Tumorbank".
Eligibility
Inclusion Criteria3
- Male/Female
- Age 18 to 90 years max.
- Just one current known malignant disease or just one current inflammatory disease
Exclusion Criteria4
- Inflammatory disease and malignant disease
- multiple malignancies
- multiple diseases
- underage
Interventions
Tissue sample is collected during therapeutic intervention by a medical doctor/surgeon. Frozen tissue sections are first transferred to Dept.of Pathology. Pathologist samples required tissue to obtain enough evidence for analysis/diagnosis. Rest tumor material with or without malignant cells is tranferred to the lab for Molecular Oncology of Prof.Zeillinger.
Samples of malignant ascites and/or malignant pleural effusion is only collected during therapeutic intervention from patients at inpatient care.
Patient is asked to give a urine sample. Urine is collected in urine beaker.
Saliva sample is collected by spatula from the mouth cavity of the patient.
Patient is asked to produce sputum into a 50ml lab tube.
Stool samples are collected prior to bowel preparation for colonoscopy. Device for sampling is provided to the patient.
Irrigation liquid is collected during routine therapeutic or diagnostic procedure, e.g. lavage of the uterine cavity and fallopian tubes of women scheduled for surgery.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01789229